<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>593</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15034567</PubmedId>
            <Abstract>Many human T-cell responses specific for epitopes in Plasmodium falciparum have been described, but none has yet been shown to be predictive of protection against natural malaria infection. Here we report a peptide-specific T-cell assay that is strongly associated with protection of humans in The Gambia, West Africa, from both malaria infection and disease. The assay detects interferon-gamma-secreting CD4(+) T cells specific for a conserved sequence from the circumsporozoite protein, which binds to many human leukocyte antigen (HLA)-DR types. The correlation was observed using a cultured, rather than an ex vivo, ELISPOT assay that measures central memory-'type T cells rather than activated effector T cells. These findings provide direct evidence for a protective role for CD4(+) T cells in humans, and a precise target for the design of improved vaccines against P. falciparum.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>406-10</ArticlePages>
            <ArticleTitle>A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Reece</LastName>
                    <ForeName>William H H</ForeName>
                </Author>
                <Author>
                    <LastName>Pinder</LastName>
                    <ForeName>Margaret</ForeName>
                </Author>
                <Author>
                    <LastName>Gothard</LastName>
                    <ForeName>Philip K</ForeName>
                </Author>
                <Author>
                    <LastName>Milligan</LastName>
                    <ForeName>Paul</ForeName>
                </Author>
                <Author>
                    <LastName>Bojang</LastName>
                    <ForeName>Kalifa</ForeName>
                </Author>
                <Author>
                    <LastName>Doherty</LastName>
                    <ForeName>Tom</ForeName>
                </Author>
                <Author>
                    <LastName>Plebanski</LastName>
                    <ForeName>Magdalena</ForeName>
                </Author>
                <Author>
                    <LastName>Akinwunmi</LastName>
                    <ForeName>Peter</ForeName>
                </Author>
                <Author>
                    <LastName>Everaere</LastName>
                    <ForeName>Simone</ForeName>
                </Author>
                <Author>
                    <LastName>Watkins</LastName>
                    <ForeName>Katherine R</ForeName>
                </Author>
                <Author>
                    <LastName>Voss</LastName>
                    <ForeName>Gerald</ForeName>
                </Author>
                <Author>
                    <LastName>Tornieporth</LastName>
                    <ForeName>Nadia</ForeName>
                </Author>
                <Author>
                    <LastName>Alloueche</LastName>
                    <ForeName>Ali</ForeName>
                </Author>
                <Author>
                    <LastName>Greenwood</LastName>
                    <ForeName>Brian M</ForeName>
                </Author>
                <Author>
                    <LastName>Kester</LastName>
                    <ForeName>Kent E</ForeName>
                </Author>
                <Author>
                    <LastName>McAdam</LastName>
                    <ForeName>Keith P W J</ForeName>
                </Author>
                <Author>
                    <LastName>Cohen</LastName>
                    <ForeName>Joe</ForeName>
                </Author>
                <Author>
                    <LastName>Hill</LastName>
                    <ForeName>Adrian V S</ForeName>
                </Author>
            </Authors>
            <Affiliations>Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.</Affiliations>
            <ArticleChemicalList>Epitopes;Protozoan Proteins;circumsporozoite protein, Protozoan</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adolescent; Adult; Amino Acid Sequence; CD4-Positive T-Lymphocytes(immunology); Conserved Sequence; Enzyme-Linked Immunosorbent Assay; Epitopes(immunology); Humans; Immunologic Memory; Malaria, Falciparum(immunology; prevention &amp; control); Middle Aged; Molecular Sequence Data; Protozoan Proteins(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>10</Volume>
                <Issue>4</Issue>
                <Title>Nature medicine</Title>
                <Issn>1078-8956</Issn>
                <MedlineTa>Nat Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Peptide 22</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DIEKKICKMEKCSSV</LinearSequence>
                        <StartingPosition>378</StartingPosition>
                        <EndingPosition>392</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>pg407 Table 1</LocationOfData>
                <EpitopeId>8631</EpitopeId>
                <ReferenceStartingPosition>378</ReferenceStartingPosition>
                <ReferenceEndingPosition>392</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>5443</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>18-45 years</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>326</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Circumsporozoite protein (CS)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAK62977.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>AS02 (SBAS2)</Adjuvant>
                                <DoseSchedule>Three doses of malaria vaccine (RTS,S/AS02)</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                            </InVitroAdministration>
                            <ImmunizationComments>Subjects were vaccinated with malaria vaccine(RTS,S) vaccine along with AS02 adjuvant. RTS,S consists of c-terminus of cs protein fused to the hepatitis B surface antigen.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 22</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DIEKKICKMEKCSSV</LinearSequence>
                                        <StartingPosition>378</StartingPosition>
                                        <EndingPosition>392</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The effect of vaccination with malaria vaccine (RTS,S/AS02) over the time course (three vaccination followed by exposure to natural infection for 150 days) produced a limited increase in the mean cultured ELISPOT response to the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2 and Fig 1b</LocationOfData>
                        <TCellId>5563</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>18-45 years</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>326</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Circumsporozoite protein (CS)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAK62977.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>AS02 (SBAS2)</Adjuvant>
                                <DoseSchedule>Three doses of malaria vaccine (RTS,S/AS02)</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                            </InVitroAdministration>
                            <ImmunizationComments>Subjects were vaccinated with malaria vaccine(RTS,S) vaccine along with AS02 adjuvant. RTS,S consists of c-terminus of cs protein fused to the hepatitis B surface antigen.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 22</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DIEKKICKMEKCSSV</LinearSequence>
                                        <StartingPosition>378</StartingPosition>
                                        <EndingPosition>392</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Cultured ELISPOT response was measured at start of the malaria season (2 weeks after thrid vaccination with malaria vaccine (RTS,S/AS02).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5505</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>18-45 years</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>326</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Circumsporozoite protein (CS)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAK62977.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>AS02 (SBAS2)</Adjuvant>
                                <DoseSchedule>Three doses of malaria vaccine (RTS,S/AS02)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Subjects were vaccinated with malaria vaccine(RTS,S) vaccine along with AS02 adjuvant. RTS,S consists of c-terminus of cs protein fused to the hepatitis B surface antigen.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 22</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DIEKKICKMEKCSSV</LinearSequence>
                                        <StartingPosition>378</StartingPosition>
                                        <EndingPosition>392</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide 35</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DKHIKEYLNKIQNSL</LinearSequence>
                        <StartingPosition>286</StartingPosition>
                        <EndingPosition>300</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAW78209.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>pg407 Table 1</LocationOfData>
                <EpitopeId>8881</EpitopeId>
                <ReferenceStartingPosition>328</ReferenceStartingPosition>
                <ReferenceEndingPosition>342</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>5506</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>18-45 years</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>326</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAW78209.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Circumsporozoite protein (CS)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>AAK62977.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>AS02 (SBAS2)</Adjuvant>
                                <DoseSchedule>Three doses of malaria vaccine (RTS,S/AS02)</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                            </InVitroAdministration>
                            <ImmunizationComments>Subjects were vaccinated with malaria vaccine(RTS,S) vaccine along with AS02 adjuvant. RTS,S consists of c-terminus of cs protein fused to the hepatitis B surface antigen.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>326</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Peptide 35</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DKHIKEYLNKIQNSL</LinearSequence>
                                        <StartingPosition>286</StartingPosition>
                                        <EndingPosition>300</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAW78209.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Cultured ELISPOT response was measured at start of the malaria season (2 weeks after thrid vaccination with malaria vaccine (RTS,S/AS02).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

